InvestorsHub Logo
Followers 33
Posts 2840
Boards Moderated 2
Alias Born 10/24/2015

Re: None

Sunday, 03/17/2024 7:24:57 PM

Sunday, March 17, 2024 7:24:57 PM

Post# of 43
AACR abstract

1333 / 16 - Preclinical data supporting the Phase 1 trial design of SENTI-202, a next generation allogeneic logic-gated selective CAR NK cell therapy, engineered to overcome key limitations of first generation cell therapies in AML https://www.abstractsonline.com/pp8/#!/20272/presentation/6026
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SNTI News